<DOC>
	<DOCNO>NCT02903121</DOCNO>
	<brief_summary>The etonogestrel ( ENG ) subdermal contraceptive implant ( ENG implant ) highly effective method prevent pregnancy , bleed side effect make unappealing many woman . The study demonstrate sustain reduction bleed last two month selective estrogen receptor modulator ( SERM ) tamoxifen user levonogestrel ( LNG ) contraceptive implant . Based investigator encourage preliminary data tamoxifen ENG implant user , investigator plan perform additional study impact tamoxifen breakthrough bleed experience ENG implant user .</brief_summary>
	<brief_title>Treatment Unfavorable Bleeding Patterns Contraceptive Implant Users</brief_title>
	<detailed_description>The investigator perform 2 phase trial treatment woman experience frequent prolonged bleeding use ENG contraceptive implant . The first phase consist randomize , control , double blind placebo-controlled clinical trial 90-day reference period second phase allow study arm receive open-label treatment additional 90-day reference period . The primary outcome study total number consecutive bleeding-free day first 30 day Day 1 first treatment ( TX1 ) .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>English Spanish speak woman age 1545 year age Currently use ENGimplant least 1 month use proven exam ( palpation implant screen visit ) Willing continue use implant least 6 month &gt; 7 day continuous bleeding/spotting , 2 episode bleeding/spotting last 30 day . Cellphone able receive respond daily text email message . Postpartum within six month postabortion within six week currently pregnant currently breastfeed undiagnosed abnormal uterine bleed predate placement contraceptive implant bleed dyscrasia anticoagulation use active cervicitis allergy tamoxifen history venous thromboembolism current past breast uterine malignancy use medication contraindicate tamoxifen ( coumadin , letrozole , bromocriptine , rifampicin , aminoglutethimide , phenobarbital ) .</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Unscheduled bleeding</keyword>
	<keyword>Long act contraception</keyword>
</DOC>